{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:02:27Z","timestamp":1791561747399,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejca.2015.12.015","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T17:15:14Z","timestamp":1453828514000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"C","title":["Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)"],"prefix":"10.1016","volume":"56","author":[{"given":"T.","family":"Valentin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Le Cesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Decanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Isambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Linassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.O.","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bellesoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Penel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Le Guellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Filleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chevreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejca.2015.12.015_bib1","first-page":"2597","article-title":"Incidence and survival in sarcoma in the United States: a focus on musculoskeletal lesions","volume":"33","author":"Ng","year":"2013","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.ejca.2015.12.015_bib2","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2015.12.015_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0360-3016(98)00223-5","article-title":"Malignant peripheral nerve sheath tumor: analysis of treatment outcome","volume":"42","author":"Wong","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejca.2015.12.015_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution","volume":"107","author":"Anghileri","year":"2006","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2015.12.015_bib5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181a77e9a","article-title":"Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome","volume":"249","author":"Zou","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2015.12.015_bib6","article-title":"Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors","author":"LaFemina","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2015.12.015_bib7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1245\/s10434-011-1978-7","article-title":"Malignant peripheral nerve sheath tumors (MPNST): the\u00a0Mayo clinic experience","volume":"19","author":"Stucky","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2015.12.015_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumors in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejca.2015.12.015_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jmg.2006.048140","article-title":"Further evidence of the increased risk for malignant peripheral nerve sheath tumor from a Scottish cohort of patients with neurofibromatosis type 1","volume":"44","author":"McCaughan","year":"2007","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.ejca.2015.12.015_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1179\/joc.2010.22.6.413","article-title":"High grade malignant peripheral nerve sheath tumors: outcome of 62 patients with localized disease and review of the literature","volume":"22","author":"Longhi","year":"2010","journal-title":"J Chemother"},{"key":"10.1016\/j.ejca.2015.12.015_bib11","doi-asserted-by":"crossref","first-page":"756395","DOI":"10.1155\/2009\/756395","article-title":"Survival in malignant peripheral nerve sheath tumors: a comparison between sporadic and neurofibromatosis type 1-associated tumors","volume":"2009","author":"Porter","year":"2009","journal-title":"Sarcoma"},{"issue":"10","key":"10.1016\/j.ejca.2015.12.015_bib12","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/1097-0142(19810515)47:10<2503::AID-CNCR2820471033>3.0.CO;2-3","article-title":"Malignant schwannoma\u2013clinical characteristics, survival, and response to therapy","volume":"47","author":"Sordillo","year":"1981","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2015.12.015_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/neuonc\/nos287","article-title":"Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1","volume":"15","author":"Kolberg","year":"2013","journal-title":"Neuro Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.ejca.2015.12.015_bib14","first-page":"iii102","article-title":"Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2015.12.015_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7150\/jca.4179","article-title":"Malignant peripheral nerve sheath tumors: differentiation patterns and immunohistochemical features \u2013 a mini-review and our new findings","volume":"3","author":"Guo","year":"2012","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2015.12.015_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00401-012-0954-z","article-title":"Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems","volume":"123","author":"Rodriguez","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.ejca.2015.12.015_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/humu.9245","article-title":"Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1","volume":"23","author":"De Luca","year":"2004","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.ejca.2015.12.015_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jmg.26.11.704","article-title":"A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity","volume":"26","author":"Huson","year":"1989","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.ejca.2015.12.015_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.ejhg.5201676","article-title":"Neurofibromatosis 1","volume":"15","author":"Ferner","year":"2007","journal-title":"Eur J Hum Genet"},{"issue":"18","key":"10.1016\/j.ejca.2015.12.015_bib20","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.ejca.2011.05.031","article-title":"Malignant peripheral nerve sheath tumors in NF1: improved survival in women and in recent years","volume":"47","author":"Ingham","year":"2011","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2015.12.015_bib21","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.5858\/2006-130-1448-GOSTSR","article-title":"Grading of soft tissue sarcomas: review and update","volume":"130","author":"Coindre","year":"2006","journal-title":"Arch Pathol Lab Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915011594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915011594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T09:32:48Z","timestamp":1654162368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915011594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":21,"alternative-id":["S0959804915011594"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.12.015","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}